Enabling ID Resolution at Scale with Multi-party Data Linking
Cookies are going stale! Time to talk to an identity resolution expert.
With Google’s looming deprecation of cookies, Medicx has been at work solving for new, and perhaps even greater challenges of efficiently reaching and measuring the effectiveness of omnichannel campaigns.
According to Statcounter:
78%
of brands entered 2022 with no solution in place to transition away from cookie-based targeting.
81%
of marketers still depend on cookies for their current marketing strategies.
55%
of marketers aren’t ready for cookie deprecation.
Enter MX#™
Medicx has developed an award winning multi-party data linking technology — a new approach to advanced ID resolution that combines the fidelity of first-party data with the privacy of hashed, third-party identifiers. MX# creates digital identities by encrypting and linking first-, second-, and third-party data from reliable sources, maintaining data privacy while maximizing precision.
With MX#, Pharma Brand Marketers Benefit From:
Privacy Safe Compliance
- Reliable, privacy-safe consumer, patient, and HCP data
Better Performance Measurement
- Industry-leading match rates across touchpoints to improve performance measurement
Increased Campaign Scalability
- High-fidelity deterministic data that increases campaign scalability and confidence
Ongoing Brand Optimization
- Breadth and depth of patient and HCP insights
Emerging Media Performance
- Proven performance for cookieless media
Enhanced Targeting Coverage
- Increased access to patients and HCPs using iOS Safari, Firefox & MS Edge
With MX#, pharma brand marketers benefit from:
Privacy-safe Compliance
Reliable, privacy-safe consumer, patient,
and HCP data
Better Performance Measurement
Industry-leading match rates across touchpoints to improve performance measurement
Increased Campaign Scalability
High-fidelity deterministic data that increases campaign scalability and confidence
Ongoing Brand Optimization
Breadth and depth of patient and HCP insights for brand optimization
Emerging Media Performance
Proven performance for cookieless media such as OTT/CTV
Enhanced Targeting Coverage
Increased access to patients and HCPs using iOS Safari, Firefox & MS Edge
Unique Reach. Lower Cost Per Acquisition. Better Audience Quality.
Medicx differs by offering a significant improvement in reach and resolution to high value patients, including those with rare diseases and cancers, which creates larger pools for enhanced performance measurement, audience quality, script lift analysis, and ROI confidence.
MX# leverages real-world evidence and the ability to measure and optimize across a wide array of promotional channels.
It’s complicated, but it doesn’t have to be. Let’s talk about how Medicx can improve audience quality and performance.
>> Trust our experience and domain expertise in the area of pharmaceutical omni-channel marketing.
Send a message. Our team will get right back to you.